Correspondence 0001493152-26-000708 from Propanc Biopharma, Inc. (PPCB)

Propanc Biopharma, Inc.
Date: Jan. 6, 2026 · CIK: 0001517681 · Accession: 0001493152-26-000708

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-292473

Date

December 30, 2025

Author

Very

Form

CORRESP

Company

Propanc Biopharma, Inc.

Letter

Re: Propanc Biopharma, Inc.

January 7, 2026

United States Securities and Exchange Commission

Division of Corporation Finance

Attn: Jessica Dickerson

F Street, N.E.

Washington, DC 20549

Registration Statement on Form S-1

Filed December 30, 2025

File No. 333-292473

Ladies and Gentlemen:

The undersigned registrant (the "Registrant") hereby requests that the Securities and Exchange Commission (the "Commission") take appropriate action to cause the above-referenced Registration Statement on Form S-1 to become effective on January 9, 2026 at 12:00 p.m. Eastern Standard Time, or as soon thereafter as practicable.

The Registrant authorizes Chase Chandler of Brunson Chandler & Jones, PLLC, outside counsel to the Registrant, to verbally alter the requested date and time of effectiveness of the Registration Statement with the Commission. Please call Mr. Chandler at (801) 303-5772 with any questions.

Very
truly yours,
Propanc Biopharma, Inc.

Show Raw Text

CORRESP
 1
 filename1.htm

 January
7, 2026

 United
States Securities and Exchange Commission

 Division
of Corporation Finance

 Attn:
Jessica Dickerson

 100
F Street, N.E.

 Washington,
DC 20549

 Re:
 Propanc Biopharma, Inc.

 Registration Statement
 on Form S-1

 Filed December 30, 2025

 File No. 333-292473

 Ladies
and Gentlemen:

 The
undersigned registrant (the "Registrant") hereby requests that the Securities and Exchange Commission (the "Commission")
take appropriate action to cause the above-referenced Registration Statement on Form S-1 to become effective on January 9, 2026 at 12:00
p.m. Eastern Standard Time, or as soon thereafter as practicable.

 The
Registrant authorizes Chase Chandler of Brunson Chandler & Jones, PLLC, outside counsel to the Registrant, to verbally alter the
requested date and time of effectiveness of the Registration Statement with the Commission. Please call Mr. Chandler at (801) 303-5772
with any questions.

 Very
truly yours,

 Propanc Biopharma, Inc.

 /s/
 James Nathanilesz

 James Nathanilesz

 Chief Executive Officer

SecProbe.io